Amgen, AbbVie say IRA negotiations impacted Q1 salesnews2026-05-06T19:05:40+00:00May 6th, 2026|Endpoints News|
Lilly plans new $4.5B manufacturing investment in Indiananews2026-05-06T18:25:24+00:00May 6th, 2026|Endpoints News|
BeOne culls five cancer programs and an autoimmune Phase 2news2026-05-06T18:22:20+00:00May 6th, 2026|Endpoints News|
Lonza looks to ride ADC wave with upcoming factory, workforce expansionnews2026-05-06T18:06:38+00:00May 6th, 2026|Endpoints News|
Madrigal’s Rezdiffra beats estimates; Gilead cuts jobs; Banyan debutsnews2026-05-06T15:17:19+00:00May 6th, 2026|Endpoints News|
Former Orbital scientists launch new mRNA therapy startupnews2026-05-06T15:17:04+00:00May 6th, 2026|Endpoints News|
Avalo scores Phase 2 success in comeback bid, raises $375Mnews2026-05-06T15:00:17+00:00May 6th, 2026|Endpoints News|
GSK goes to China for $1B siRNA deal in Arrowhead’s obesity lanenews2026-05-06T13:39:55+00:00May 6th, 2026|Endpoints News|
CellCentric raises $220M to get multiple myeloma pill to marketnews2026-05-06T11:00:47+00:00May 6th, 2026|Endpoints News|
Bayer to buy Perfuse Therapeutics for $300M upfrontnews2026-05-06T10:56:39+00:00May 6th, 2026|Endpoints News|
